JP2012509886A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012509886A5 JP2012509886A5 JP2011537606A JP2011537606A JP2012509886A5 JP 2012509886 A5 JP2012509886 A5 JP 2012509886A5 JP 2011537606 A JP2011537606 A JP 2011537606A JP 2011537606 A JP2011537606 A JP 2011537606A JP 2012509886 A5 JP2012509886 A5 JP 2012509886A5
- Authority
- JP
- Japan
- Prior art keywords
- tcl1
- activator protein
- promotes
- pharmaceutical composition
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102100012473 JUND Human genes 0.000 claims 26
- 108010018242 Transcription Factor AP-1 Proteins 0.000 claims 26
- 101700039223 TCL1A Proteins 0.000 claims 13
- 230000000694 effects Effects 0.000 claims 6
- 102000004965 antibodies Human genes 0.000 claims 5
- 108090001123 antibodies Proteins 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 241000124008 Mammalia Species 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 230000003278 mimic Effects 0.000 claims 3
- 230000000051 modifying Effects 0.000 claims 3
- 102000030951 Phosphotransferases Human genes 0.000 claims 2
- 108091000081 Phosphotransferases Proteins 0.000 claims 2
- 230000004913 activation Effects 0.000 claims 2
- 230000003042 antagnostic Effects 0.000 claims 2
- 239000005557 antagonist Substances 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 230000003993 interaction Effects 0.000 claims 1
Claims (7)
- Tcl1上のエピトープに結合する抗体であって、当該抗体は、当該エピトープとアクチベータータンパク質1(AP−1)の間の相互作用、の少なくとも1つを調節する、前記抗体。
- 請求項1に記載の抗体を含む、医薬組成物。
- 哺乳動物においてアクチベータータンパク質1(AP−1)の活性が改変される、B−CLL疾患状態を治療するための医薬組成物であって、Tcl1タンパク質上のエピトープに結合可能な抗体を含み、ここで当該抗体はTcl1が増進するアクチベータータンパク質1(AP−1)の活性を調節する、前記医薬組成物。
- 哺乳動物においてアクチベータータンパク質1(AP−1)の活性が改変される、B−CLL疾患状態を治療するための医薬組成物であって、アクチベータータンパク質1(AP−1)のペプチド断片を含み、ここで当該ペプチド断片は、アクチベータータンパク質1(AP−1)に結合し、そして、Tcl1が増進するアクチベータータンパク質1(AP−1)のキナーゼ活性を調節する、前記医薬組成物。
- Tcl1模倣体を含む化合物であって、当該Tcl1模倣体は、いかなる細胞においてもアクチベータータンパク質1(AP−1)に結合し、そしてTcl1が増進するアクチベータータンパク質1(AP−1)の活性化を模倣するのに機能的に活性である、前記化合物。
- 哺乳動物においてアクチベータータンパク質1(AP−1)の活性が改変される、B−CLL疾患状態を治療するための医薬組成物であって、Tcl1模倣体を含み、ここで当該Tcl1模倣体は、アクチベータータンパク質1(AP−1)に結合し、そして、Tcl1が増進するアクチベータータンパク質1(AP−1)のキナーゼ活性を活性化する、前記医薬組成物。
- Tcl1アンタゴニストを含む化合物であって、ここで当該Tcl1アンタゴニストは、いかなる細胞においてもアクチベータータンパク質1(AP−1)に結合し、そしてTcl1が増進するアクチベータータンパク質1(AP−1)の活性化を調節するのに機能的に活性である、前記化合物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11678608P | 2008-11-21 | 2008-11-21 | |
US61/116,786 | 2008-11-21 | ||
PCT/US2009/065072 WO2010059779A1 (en) | 2008-11-21 | 2009-11-19 | Tcl1 AS A TRANSCRIPTIONAL REGULATOR |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012509886A JP2012509886A (ja) | 2012-04-26 |
JP2012509886A5 true JP2012509886A5 (ja) | 2012-06-07 |
Family
ID=42198493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011537606A Pending JP2012509886A (ja) | 2008-11-21 | 2009-11-19 | 転写制御因子としてのTcl1 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20110311555A1 (ja) |
EP (1) | EP2352524A1 (ja) |
JP (1) | JP2012509886A (ja) |
CN (1) | CN102271706A (ja) |
AU (1) | AU2009316584A1 (ja) |
CA (1) | CA2744326A1 (ja) |
WO (1) | WO2010059779A1 (ja) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103866018B (zh) | 2005-08-01 | 2016-05-25 | 俄亥俄州立大学研究基金会 | 用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物 |
AU2007205257B2 (en) | 2006-01-05 | 2013-07-25 | The Ohio State University Research Foundation | MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors |
ES2527592T3 (es) | 2006-01-05 | 2015-01-27 | The Ohio State University Research Foundation | Métodos basados en microARN para el diagnóstico del cáncer de colon |
EP2502630B1 (en) | 2006-01-05 | 2015-03-11 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer |
AU2007227423B2 (en) | 2006-03-20 | 2013-11-07 | The Ohio State University Research Foundation | MicroRNA fingerprints during human megakaryocytopoiesis |
AU2007272947B2 (en) | 2006-07-13 | 2013-06-06 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Micro-RNA-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases |
AU2007346101B2 (en) | 2006-09-19 | 2013-08-15 | The Ohio State University Research Foundation | TCL1 expression in chronic lymphocytic leukemia (CLL) regulated by miR-29 and miR-181 |
CA2667617A1 (en) | 2006-11-01 | 2008-05-08 | The Ohio State University Research Foundation | Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma |
WO2008094545A2 (en) | 2007-01-31 | 2008-08-07 | The Ohio State University Research Foundation | Mic orna-based methods and compositions for the treatment of acute myeloid leukemia |
US8465917B2 (en) | 2007-06-08 | 2013-06-18 | The Ohio State University Research Foundation | Methods for determining heptocellular carcinoma subtype and detecting hepatic cancer stem cells |
CN101918424A (zh) | 2007-06-15 | 2010-12-15 | 俄亥俄州立大学研究基金会 | 用于靶向由Drosha介导的微小RNA加工的致癌ALL-1融合蛋白 |
CN101809169B (zh) | 2007-07-31 | 2013-07-17 | 俄亥俄州立大学研究基金会 | 通过靶向dnmt3a和dnmt3b恢复甲基化的方法 |
US8465918B2 (en) | 2007-08-03 | 2013-06-18 | The Ohio State University Research Foundation | Ultraconserved regions encoding ncRNAs |
CA2926831A1 (en) | 2007-08-22 | 2009-02-26 | The Ohio State University Research Foundation | Methods and compositions for inducing deregulation of epha7 and erk phosphorylation in human acute leukemias |
EP2201112A4 (en) | 2007-10-26 | 2011-02-02 | Univ Ohio State Res Found | METHODS FOR IDENTIFYING INTERACTION OF THE "FRAGILE HISTIDINE TRIAD" GENE (FHIT) AND USES THEREOF |
ES2433940T3 (es) | 2008-06-11 | 2013-12-13 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Uso de la familia miR-26 como marcador predictivo del carcinoma hepatocelular y sensibilidad a la terapia |
CN102803511A (zh) | 2009-11-23 | 2012-11-28 | 俄亥俄州立大学 | 用于影响肿瘤细胞生长、迁移和侵袭的材料和方法 |
WO2012065049A1 (en) | 2010-11-12 | 2012-05-18 | The Ohio State University Research Foundation | Materials and methods related to microrna-21, mismatch repair, and colorectal cancer |
CA2817982C (en) | 2010-11-15 | 2020-06-30 | The Regents Of The University Of Michigan | Controlled release mucoadhesive systems |
US8664192B2 (en) | 2011-03-07 | 2014-03-04 | The Ohio State University | Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer |
JP2014530612A (ja) | 2011-10-14 | 2014-11-20 | ジ・オハイオ・ステート・ユニバーシティ | 卵巣がんに関する方法および材料 |
CN104619353A (zh) | 2011-12-13 | 2015-05-13 | 俄亥俄州国家创新基金会 | 与miR-21和miR-29a相关的方法和组合物、外切体抑制和癌症转移 |
WO2013110053A1 (en) | 2012-01-20 | 2013-07-25 | The Ohio State University | Breast cancer biomarker signatures for invasiveness and prognosis |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5985598A (en) * | 1994-10-27 | 1999-11-16 | Thomas Jefferson University | TCL-1 gene and protein and related methods and compositions |
US20010026796A1 (en) * | 2000-03-14 | 2001-10-04 | Croce Carlo M. | TCL1 enhances Akt kinase activity and mediates its nuclear translocation |
GB0128898D0 (en) * | 2001-12-03 | 2002-01-23 | Biotech Res Ventures Pte Ltd | Materials and methods relating to the stabilization and activation of a tumour suppressor protein |
EP1507773B1 (en) * | 2002-03-08 | 2015-09-16 | Eisai R&D Management Co., Ltd. | Macrocyclic compounds useful as pharmaceuticals |
-
2009
- 2009-11-19 JP JP2011537606A patent/JP2012509886A/ja active Pending
- 2009-11-19 US US13/129,881 patent/US20110311555A1/en not_active Abandoned
- 2009-11-19 WO PCT/US2009/065072 patent/WO2010059779A1/en active Application Filing
- 2009-11-19 EP EP09828195A patent/EP2352524A1/en not_active Withdrawn
- 2009-11-19 CA CA2744326A patent/CA2744326A1/en not_active Abandoned
- 2009-11-19 CN CN2009801530248A patent/CN102271706A/zh active Pending
- 2009-11-19 AU AU2009316584A patent/AU2009316584A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2012509886A5 (ja) | ||
HRP20190312T1 (hr) | Vežući proteini, uključujući protutijela, derivate protutijela i fragmente protutijela, koji se specifično vežu na cd154 i njihova upotreba | |
EA200870265A1 (ru) | Функционально активные антитела | |
HRP20192295T1 (hr) | Optimizirana monoklonska protutijela protiv inhibitora faktora tkivnog puta (tfpi) | |
WO2006122257A3 (en) | Nebulization of monoclonal antibodies for treating pulmonary diseases | |
WO2019178269A3 (en) | Antibodies that bind cd39 and uses thereof | |
WO2013051878A3 (en) | Antibody specifically binding to epitope in sema domain of c-met | |
UA113712C2 (xx) | Антитіло до fap і способи його застосування | |
IL186671A (en) | Monoclonal antibodies that bind specifically to the amyloid-cell peptide, methods of making them, pharmaceutical preparations that include them and their use in the manufacture of drugs | |
JP2007051159A5 (ja) | ||
MX2012012927A (es) | Composiciones y metodos de uso para anticuerpos multivalentes terapeuticos de proteina relacionada con lipoproteina de baja densidad 6 (lrp6). | |
NZ585465A (en) | Monoclonal antibodies which bind to the extracellular domain of the axl receptor tyrosine kinase | |
BR112012013876A2 (pt) | proteínas de ligação do antígeno humano que ligam o seu b-klotho, receptores de fgf e seus complexos | |
JP2007520566A5 (ja) | ||
AR057807A1 (es) | Formulaciones de anticuerpo anti-cd3 | |
EA201700111A1 (ru) | Полипептидные конструкции и их применение | |
JP2015500002A5 (ja) | ||
GEP20135930B (en) | ANTI-cMET ANTIBODY | |
IL198379A (en) | Human antibodies and antibodies that bind sphingosine-1-phosphate, their encoded nucleic acids, and their preparations and methods for treating the disease | |
BRPI0607349A2 (pt) | combinação de xolair com agente imunossupressor | |
EA200901421A1 (ru) | Антитела к il-25 | |
ATE497392T1 (de) | Therapie mit anti-cd4-antikörpern und bestrahlung | |
NO20091181L (no) | Anti-C5AR-antistoffer med forbedrede egenskaper | |
WO2008049990A3 (fr) | Utilisation d'un anticorps anti-cd151 pour le traitement du cancer | |
MX2009005103A (es) | Conjugado anti-idiotipo y su uso como un estandar en un inmunoensayo. |